Linagliptin is a medicine used in the management of diabetes. It promotes insulin levels within the body to assist in lowering elevated blood sugar.
Managing blood sugar levels requires effective tools. Linagliptin acts as a dipeptidyl peptidase-4 (DPP-4) inhibitor, which belongs to a class of compounds that help control blood glucose in adults. You may encounter this active ingredient in, or combined with other substances within, medicines such as Glyxambi, Jentadueto XR, and Tradjenta.
This medicine supports your body in lowering blood sugar. It works alongside diet and exercise to reach target glucose levels.
Addressing high blood sugar levels often involves the use of this ingredient. It is primarily used to help adults manage type 2 diabetes. By keeping glucose within a more stable range, it supports your long-term health goals.
Healthcare providers may suggest this medicine when diet changes alone do not provide enough control. It can be used alone or in combination with other blood-sugar-lowering medicines. It does not treat type 1 diabetes or diabetic ketoacidosis.
Natural body processes regulate your internal sugar balance after you eat. Linagliptin works by blocking an enzyme that destroys hormones known as incretins.
These incretin hormones prompt your pancreas to release more insulin when your sugar level is high. Simultaneously, they signal your liver to produce less sugar. This balance helps your body respond to your meals more effectively.
Your health history helps determine if this medicine fits your needs. Inform your healthcare professional if you have a history of pancreatitis, gallbladder issues, or kidney concerns before starting this therapy.
Be aware that certain conditions may influence how your body handles this ingredient:
Always review the printed patient information leaflet included with your specific product for precise safety warnings.
Unexpected physical changes can occur during your treatment course.
Individuals with a specific history of pancreas inflammation face a higher chance of complications. You should be especially mindful if you take other medicines that also lower blood sugar, as the risk of low glucose levels may increase.
Maintain the quality of your medicine by keeping it in its original packaging between 20°C and 25°C. Protect the tablets from moisture and direct light by storing them in a cool, dry place away from children. Always check your specific product packaging for expiration dates and handling instructions. For detailed usage, dosing, and administration, refer to the specific medication's labeling.
This article provides an educational overview of Linagliptin and does not serve as medical advice. Products such as Glyxambi, Jentadueto XR, and Tradjenta vary in their specific formulation, strength, and directions for use. This content does not cover clinical interpretation or personal misuse. Always review the specific medication's labeling or packaging insert to understand your treatment, and speak with your healthcare professional regarding any specific concerns about your condition.
These resources offer additional information regarding this medicine:
